Price T Rowe Associates Inc Orchard Therapeutics PLC Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $1.54 Million - $2.97 Million	-1,330,370 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.24 - $4.29 $27,973 - $53,573	-12,488 Reduced 0.93%	1,330,370 $3.06 Million
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $29,294 - $48,245	-6,673 Reduced 0.49%	1,342,858 $5.9 Million
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $5,724 - $11,840	-1,304 Reduced 0.1%	1,349,531 $9.8 Million
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $5.21 Million - $6.85 Million	1,350,835 New	1,350,835 $5.84 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.